首页> 外文期刊>The Open Ophthalmology Journal >Contrast Sensitivity in Patients with Beta-Thalassemia Major and Sickle Cell Disease Under Regular Transfusions and Treatment with Desferrioxamine
【24h】

Contrast Sensitivity in Patients with Beta-Thalassemia Major and Sickle Cell Disease Under Regular Transfusions and Treatment with Desferrioxamine

机译:定期输血和去铁胺治疗的严重β-地中海贫血和镰状细胞病患者的对比敏感性

获取原文
       

摘要

Purpose: Evaluation of contrast sensitivity in patients with beta-thalassemia major and sickle cell disease which undergo regular transfusions and chelation therapy with desferrioxamine (DFX).
机译:目的:评估β-地中海贫血和镰状细胞病患者的对比敏感性,这些患者接受定期输血和去铁胺(DFX)螯合治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号